AMPH Expected Move
The expected move for Amphastar Pharmaceuticals Inc (AMPH) options expiring Jun 17, 2027 (207 DTE) is ±$6.99 (±24.7%), a range of $21.27 to $35.25.
AMPH Expected Move by Expiry
The expected move for all expiration dates of AMPH.
| Expiration | Expected Move ($) | Expected Move (%) | Lower Price | Upper Price | Implied Volatility |
|---|---|---|---|---|---|
| Nov 20, 2026 -2 DTE monthly expired | - | - | - | - | - |
| Dec 18, 2026 26 DTE monthly | - | - | - | - | - |
| Jan 15, 2027 54 DTE monthly | ±$4.48 | ±15.84% | $23.79 | $32.74 | - |
| Mar 19, 2027 117 DTE monthly | - | - | - | - | - |
| Jun 17, 2027 207 DTE weekly | ±$6.99 | ±24.73% | $21.27 | $35.25 | - |
Click row to show expected move chart for that expiration
AMPH Expected Move FAQ
What is an expected move?
The expected move is the price range that option prices imply by a given date, usually one standard deviation. The stock is expected to finish inside that range about 68% of the time.
What is AMPH's expected move this week?
As of Nov 22, 2026, the expected move for Amphastar Pharmaceuticals options expiring Friday, Jan 15, 2027 is ±$4.48 (±15.8%), a range of $23.79 to $32.74. The table above shows the current expected move for every expiration date.
How has AMPH implied volatility changed recently?
Amphastar Pharmaceuticals 30-day implied volatility went from 80.7% on Oct 23, 2026 to 55.7% on Nov 20, 2026. See the AMPH implied volatility history for a longer view.
What is Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.